These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Bierhaus A; Chevion S; Chevion M; Hofmann M; Quehenberger P; Illmer T; Luther T; Berentshtein E; Tritschler H; Müller M; Wahl P; Ziegler R; Nawroth PP Diabetes; 1997 Sep; 46(9):1481-90. PubMed ID: 9287050 [TBL] [Abstract][Full Text] [Related]
7. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Osawa T; Kato Y Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265 [TBL] [Abstract][Full Text] [Related]
8. Kaempferol modulates pro-inflammatory NF-kappaB activation by suppressing advanced glycation endproducts-induced NADPH oxidase. Kim JM; Lee EK; Kim DH; Yu BP; Chung HY Age (Dordr); 2010 Jun; 32(2):197-208. PubMed ID: 20431987 [TBL] [Abstract][Full Text] [Related]
9. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Bierhaus A; Schiekofer S; Schwaninger M; Andrassy M; Humpert PM; Chen J; Hong M; Luther T; Henle T; Klöting I; Morcos M; Hofmann M; Tritschler H; Weigle B; Kasper M; Smith M; Perry G; Schmidt AM; Stern DM; Häring HU; Schleicher E; Nawroth PP Diabetes; 2001 Dec; 50(12):2792-808. PubMed ID: 11723063 [TBL] [Abstract][Full Text] [Related]
10. Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acid. Manna P; Das J; Ghosh J; Sil PC Free Radic Biol Med; 2010 Jun; 48(11):1465-84. PubMed ID: 20188823 [TBL] [Abstract][Full Text] [Related]
11. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. Yan SD; Schmidt AM; Anderson GM; Zhang J; Brett J; Zou YS; Pinsky D; Stern D J Biol Chem; 1994 Apr; 269(13):9889-97. PubMed ID: 8144582 [TBL] [Abstract][Full Text] [Related]
12. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients. Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889 [TBL] [Abstract][Full Text] [Related]
13. Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications. Elosta A; Ghous T; Ahmed N Curr Diabetes Rev; 2012 Mar; 8(2):92-108. PubMed ID: 22268395 [TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia and the pathobiology of diabetic complications. Aronson D Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953 [TBL] [Abstract][Full Text] [Related]
15. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Hofmann MA; Schiekofer S; Isermann B; Kanitz M; Henkels M; Joswig M; Treusch A; Morcos M; Weiss T; Borcea V; Abdel Khalek AK; Amiral J; Tritschler H; Ritz E; Wahl P; Ziegler R; Bierhaus A; Nawroth PP Diabetologia; 1999 Feb; 42(2):222-32. PubMed ID: 10064103 [TBL] [Abstract][Full Text] [Related]
16. Activation of tubular epithelial cells in diabetic nephropathy. Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911 [TBL] [Abstract][Full Text] [Related]
17. [The role of carbonyl stress in the development of diabetic complications]. Makk-Merczel K; Szarka A Orv Hetil; 2019 Oct; 160(40):1567-1573. PubMed ID: 31565977 [TBL] [Abstract][Full Text] [Related]
18. [Advanced glycation end products (AGEs), free radicals and diabetes]. Gillery P J Soc Biol; 2001; 195(4):387-90. PubMed ID: 11938555 [TBL] [Abstract][Full Text] [Related]
19. The cellular and molecular mechanisms of diabetic complications. King GL; Brownlee M Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700 [TBL] [Abstract][Full Text] [Related]
20. Pioglitazone inhibits advanced glycation induced protein modifications and down-regulates expression of RAGE and NF-κB in renal cells. Adeshara KA; Agrawal SB; Gaikwad SM; Tupe RS Int J Biol Macromol; 2018 Nov; 119():1154-1163. PubMed ID: 30096396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]